MIMEDX GROUP, INC.·4

Jun 12, 11:39 AM ET

BIERMAN JAMES L 4

4 · MIMEDX GROUP, INC. · Filed Jun 12, 2026

Research Summary

AI-generated summary of this filing

Updated

MDXG Director James L. Bierman Receives Restricted Stock Award

What Happened
James L. Bierman, a director of MIMEDX Group, Inc. (MDXG), was granted 50,913 restricted shares on 2026-06-10 at an indicated price of $3.64 per share, totaling $185,323. The transaction is coded as an award/grant (A) — a compensation grant to a non-employee director rather than an open‑market purchase or sale.

Key Details

  • Transaction date: 2026-06-10; Form 4 filed 2026-06-12. Filing appears to be within the typical two-business-day window.
  • Security: Common stock — 50,913 shares; price per share shown as $3.64; total value $185,323.
  • Post-transaction holdings: Not specified in the provided filing details.
  • Footnote: Grant is the annual restricted stock award for non-employee directors, exempt under Rule 16b-3. Vesting occurs upon the earlier of 12 months or the next meeting of shareholders.
  • Transaction code: A = Award/Grant (not a purchase or sale in the open market).

Context
This is a routine director compensation grant and does not by itself signal a buy or sell decision by the director. Awards to non-employee directors are commonly granted annually and typically vest over time (here, within 12 months or at the next shareholders' meeting). Exemption under Rule 16b-3 means the grant is not subject to short-swing profit recovery.

Insider Transaction Report

Form 4
Period: 2026-06-10
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-10$3.64/sh+50,913$185,323263,684 total
Footnotes (1)
  • [F1]Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Signature
/s/ William F. Hulse as attorney in fact for James L. Bierman|2026-06-12

Documents

1 file
  • 4
    wk-form4_1781278781.xmlPrimary

    FORM 4